|
1.
|
Grines CL, Browne KF, Marco J, et al The
Primary Angioplasty in Myocardial Infarction Study Group: A
comparison of primary angioplasty with thrombolytic therapy for
acute myocardial infarction. N Engl J Med. 328:673–679. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Lee CH and Tse HF: Microvascular
obstruction after percutaneous coronary intervention. Catheter
Cardiovasc Interv. 75:369–377. 2010.PubMed/NCBI
|
|
3.
|
Eeckhout E and Kern MJ: The coronary
no-reflow phenomenon: a review of mechanisms and therapies. Eur
Heart J. 22:729–739. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Tesic MB, Stankovic G, Vukcevic V and
Ostojic MC: The use of intracoronary sodium nitroprusside to treat
no-reflow after primary percutaneous coronary intervention in acute
myocardial infarction. Herz. 35:114–118. 2010.
|
|
5.
|
Burzotta F, Trani C, Romagnoli E, et al:
Manual thrombus-aspiration improves myocardial reperfusion: the
randomized evaluation of the effect of mechanical reduction of
distal embolization by thrombus-aspiration in primary and rescue
angioplasty (REMEDIA) trial. J Am Coll Cardiol. 46:371–376. 2005.
View Article : Google Scholar
|
|
6.
|
Chaitman BR and Lim MJ: No reflow and the
quest to achieve optimal perfusion during the acute phase of
myocardial infarction. J Am Coll Cardiol. 44:313–315. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Pasceri V, Pristipino C, Pelliccia F, et
al: Effects of the nitric oxide donor nitroprusside on no-reflow
phenomenon during coronary intervention for acute myocardial
infarction. Am J Cardiol. 95:1358–1361. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Gibson CM, Cannon CP, Daley WL, et al:
TIMI frame count: a quantitative method of assessing coronary
artery flow. Circulation. 93:879–888. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Gibson CM, Cannon CP, Murphy SA, et al:
Relationship of TIMI myocardial perfusion grade to mortality after
administration of thrombolytic drugs. Circulation. 101:125–130.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
TIMI Study Group: The Thrombolysis in
Myocardial Infarction (TIMI) trial. Phase I findings. N Engl J Med.
312:932–936. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Hamada S, Nishiue T, Nakamura S, et al:
TIMI frame count immediately after primary coronary angioplasty as
a predictor of functional recovery in patients with TIMI 3
reperfused acute myocardial infarction. J Am Coll Cardiol.
38:666–671. 2001. View Article : Google Scholar
|
|
12.
|
Rezkalla SH and Kloner RA: Coronary
no-reflow phenomenon: from the experimental laboratory to the
cardiac catheterization laboratory. Catheter Cardiovasc Interv.
72:950–957. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Stone GW, Maehara A, Witzenbichler B, et
al: Intracoronary abciximab and aspiration thrombectomy in patients
with large anterior myocardial infarction: the INFUSE-AMI
randomized trial. JAMA. 307:1817–1826. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Bates JN, Baker MT, Guerra R Jr and
Harrison DG: Nitric oxide generation from nitroprusside by vascular
tissue-evidence that reduction of the nitroprusside anion and
cyanide loss are required. Biochem Pharmacol. 42(Suppl): S157–S165.
1991. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Hillegass WB, Dean NA, Liao L, Rhinehart
RG and Myers PR: Treatment of no-reflow and impaired flow with the
nitric oxide donor nitroprusside following percutaneous coronary
interventions: Initial human clinical experience. J Am Coll
Cardiol. 37:1335–1343. 2001. View Article : Google Scholar
|
|
16.
|
Traverse JH, Kinn JW, Klassen C, Duncker
DJ and Bache RJ: Nitric oxide inhibition impairs blood flow during
exercise in heart with a collateral dependent myocardial region. J
Am Coll Cardiol. 31:67–74. 1997. View Article : Google Scholar
|
|
17.
|
Hillegass WB, Dean NA, Liao L, Rhinehart
RG and Myers PR: Treatment of no-reflow and impaired flow with the
nitric oxide donor nitroprusside following percutaneous coronary
interventions: initial human clinical experience. J Am Coll
Cardiol. 37:1335–1343. 2001. View Article : Google Scholar
|
|
18.
|
Barcin C, Denktas AE, Lennon RJ, et al:
Comparison of combination therapy of adenosine and nitroprusside
with adenosine alone in the treatment of angiographic no-reflow
phenomenon. Catheter Cardiovasc Interv. 61:484–491. 2004.
View Article : Google Scholar
|
|
19.
|
Parham WA, Bouhasin A, Ciaramita JP,
Khoukaz S, Herrmann SC and Kern MJ: Coronary hyperemic dose
responses of intracoronary sodium nitroprusside. Circulation.
109:1236–1243. 2004.PubMed/NCBI
|
|
20.
|
Amit G, Cafri C, Yaroslavtsev S, et al:
Intracoronary nitroprusside for the prevention of the no-reflow
phenomenon after primary percutaneous coronary intervention in
acute myocardial infarction. Am Heart J. 152:e9–e14. 2006.
View Article : Google Scholar
|
|
21.
|
Youssef AA, Wu CJ, Hang CL, et al: Impact
of PercuSurge device conjugative with intracoronary administration
of nitroprusside on no-reflow phenomenon following primary
percutaneous coronary intervention. Circ J. 70:1538–1542. 2006.
View Article : Google Scholar
|
|
22.
|
van 't Hof AW, Liem A, Suryapranata H,
Hoorntje JC, de Boer MJ and Zijlstra F; Zwolle Myocardial
Infarction Study Group: Angiographic assessment of myocardial
reperfusion in patients treated with primary angioplasty for acute
myocardial infarction: myocardial blush grade. Circulation.
97:2302–2306. 1998.
|
|
23.
|
Lepper W, Sieswerda GT, Vanoverschelde JL,
et al: Predictive value of markers of myocardial reperfusion in
acute myocardial infarction for follow-up left ventricular
function. Am J Cardiol. 88:1358–1363. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Angeja BG, Gunda M, Murphy SA, et al: TIMI
myocardial perfusion grade and ST segment resolution: association
with infarct size as assessed by single photon emission computed
tomography imaging. Circulation. 105:282–285. 2002.
|
|
25.
|
Gibson CM, Cannon CP, Murphy SA, et al:
Relationship of the TIMI myocardial grades, flow grades, frame
count, and percutaneous coronary intervention to long-term outcomes
after thrombolytic administration in acute myocardial infarction.
Circulation. 105:1909–1913. 2002. View Article : Google Scholar
|
|
26.
|
Stone GW, Peterson MA, Lansky AJ, Dangas
G, Mehran R and Leon MB: Impact of normalized myocardial perfusion
after successful angioplasty in acute myocardial infarction. J Am
Coll Cardiol. 39:591–597. 2002. View Article : Google Scholar
|
